GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
PHIN-214 overview
PHIN-214 is under development for the treatment of portal hypertension in compensated cirrhosis. It is a terlipressin derivative administered subcutaneously and acts by targeting vasopressin V1A (V1a) receptor.
PharmaIN overview
PharmaIN is a product development biopharma company that offers drug-delivery technologies. It discovers and develops PHIN-1138 used for treatment of heart failure. Its pipeline products comprise PHIN-438, PHIN-1722, and PHIN-103 therapies for the treatment of metabolic, ascites and hepato-renal syndromes, and auto-immune syndromes, among others. PharmaIN also develops and licenses drug delivery technologies. The company offers protected graft copolymer a drug carrier technology that maximizes therapeutic potential of a drug. It operates in partnerships with other drug developers to improve and enable therapeutic molecules. PharmaIN is headquartered in Bothell, Washington, the US.
For a complete picture of PHIN-214’s drug-specific PTSR and LoA scores, buy the report here.
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.
Source link
#PHIN214 #PharmaIN #Portal #Hypertension #Likelihood #Approval
